TECENTRIQ

Hoffmann-La Roche Limited🇨🇦 Health Canada

Approval Id: 6c08c9ebb6f6585e
Drug Approval Canada Name: TECENTRIQ
Product Name: TECENTRIQ
Status: Marketed
Status Date: 2019-10-16
Original Market Date: 2019-10-16
Din: 02492393
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Schedule D , Prescription
Ahfs: 10:00.00
Atc Original: L01FF05 ATEZOLIZUMAB
Atc Name: l 01 ff 05
Aig Number: 0158930001
Company Name: Hoffmann-La Roche Limited
Company Address: 7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8

ATEZOLIZUMAB

840 MG / 14 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

6c08c9ebb6f6585e

Type

Standard